- Home
- NRIM vs LAB Comparison
NRIM vs LAB Comparison
Compare NRIM & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- LAB
- Stock Information
- Founded
- NRIM 1990
- LAB 1999
- Country
- NRIM United States
- LAB United States
- Employees
- NRIM N/A
- LAB N/A
- Industry
- NRIM Savings Institutions
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- NRIM Finance
- LAB Industrials
- Exchange
- NRIM Nasdaq
- LAB Nasdaq
- Market Cap
- NRIM 444.5M
- LAB 504.2M
- IPO Year
- NRIM N/A
- LAB 2011
- Fundamental
- Price
- NRIM $22.22
- LAB $1.19
- Analyst Decision
- NRIM
- LAB Buy
- Analyst Count
- NRIM 0
- LAB 2
- Target Price
- NRIM N/A
- LAB $2.50
- AVG Volume (30 Days)
- NRIM 108.3K
- LAB 1.6M
- Earning Date
- NRIM 10-22-2025
- LAB 11-04-2025
- Dividend Yield
- NRIM 2.88%
- LAB N/A
- EPS Growth
- NRIM 91.41
- LAB N/A
- EPS
- NRIM 2.80
- LAB N/A
- Revenue
- NRIM $201,544,000.00
- LAB $172,271,000.00
- Revenue This Year
- NRIM $11.35
- LAB N/A
- Revenue Next Year
- NRIM $7.32
- LAB N/A
- P/E Ratio
- NRIM $7.92
- LAB N/A
- Revenue Growth
- NRIM 42.34
- LAB 76.33
- 52 Week Low
- NRIM $15.92
- LAB $0.92
- 52 Week High
- NRIM $25.05
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- NRIM 25.56
- LAB 39.91
- Support Level
- NRIM $20.70
- LAB $1.26
- Resistance Level
- NRIM $21.60
- LAB $1.44
- Average True Range (ATR)
- NRIM 0.76
- LAB 0.09
- MACD
- NRIM 2.54
- LAB -0.01
- Stochastic Oscillator
- NRIM 74.54
- LAB 5.44
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.